Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

661 articles

Research Review

Showing 1–3 of 3 articles · Keyword: Nanotechnology Clear keyword

Drug discovery today2026ReviewNon-viral Gene DeliveryDrug Delivery

1. Harnessing exosomes for breast cancer: bridging conceptual promise to tangible translational application

Kaur S, Harish V, Bashir B, Kolekar Ka, Singh Sk

Exosomes have been described as emerging nanocarriers that have potential for the targeted delivery of therapeutics. They offer many advantages over traditional drug delivery systems, such as their intrinsic biocompatibility, low immunogenicity, and prolonged circulation, as well as crossing biological barriers. This…

Read the article

Assay and drug development technologies2026ReviewDrug Delivery

2. Translational Strategies in Smart Drug Delivery Systems for Controlled and Personalized Pharmacokinetics

Thalluri C, Bukke Spn, Medhi J, Vasam M, Vidiyala N, Sunkishala P, Et Al.

Advancements in drug delivery systems (DDSs) have developed pharmacotherapy by enabling precise control over drug pharmacokinetics (PKs), enhancing therapeutic efficacy, minimizing toxicity, and improving patient compliance. This review comprehensively examines emerging DDS strategies designed to optimize absorption…

Read the article

Frontiers in pharmacology2026ReviewDrug Delivery

3. Multi-target neuroprotective mechanisms of epigallocatechin-3-gallate (EGCG) in stroke: from molecular pathways to nanomedicine delivery and clinical translation

Yuan Y, Xie C, Huang Y, Xi J, Wang P, Chen Z, Et Al.

Stroke ranks among the leading global causes of mortality and permanent disability. Its secondary brain injury arises from multiple interrelated pathological cascades, including oxidative stress, neuroinflammation, disrupted autophagy-apoptosis balance, excitotoxicity, iron dyshomeostasis, and blood-brain barrier…

Read the article

Let's engineer the next delivery breakthrough together

We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.

ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.